Literature DB >> 15723535

Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA.

Gaëlle Kolb1, Sandrine Reigadas, Claudine Boiziau, Arthur van Aerschot, Andrey Arzumanov, Michael J Gait, Piet Herdewijn, Jean-Jacques Toulmé.   

Abstract

The transactivation responsive element (TAR) plays a crucial role in the transcription of the HIV-1 genome upon specific binding of the viral protein Tat and cellular proteins. We have previously identified a RNA hairpin aptamer forming a stable and specific kissing complex with TAR RNA (Ducongé, F., and Toulmé, J. J. (1999) RNA 5, 1605-1614). We chemically modified this aptamer with hexitol nucleic acid (HNA) residues. We demonstrate that a fully HNA-modified aptamer is a poor ligand but, in contrast, mixmers containing both HNA and unmodified RNA nucleotides display interesting properties. Two HNA-RNA mixmers bind to TAR with an equilibrium dissociation constant in the low-nanomolar range and show a reduced nuclease sensitivity. In addition, they show a moderate dependence on magnesium ions for binding to TAR. These HNA-RNA mixmers are able to inhibit transactivation of transcription in an in vitro assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723535     DOI: 10.1021/bi048393s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.

Authors:  Dorota Kaniowska; Rafal Kaminski; Shohreh Amini; Sujatha Radhakrishnan; Jay Rappaport; Edward Johnson; Kamel Khalili; Luis Del Valle; Armine Darbinyan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex.

Authors:  Hélène Van Melckebeke; Matthew Devany; Carmelo Di Primo; François Beaurain; Jean-Jacques Toulmé; David L Bryce; Jérôme Boisbouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

3.  Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.

Authors:  Miguel Stevens; Michela Pollicita; Christophe Pannecouque; Erik Verbeken; Oriana Tabarrini; Violetta Cecchetti; Stefano Aquaro; Carlo Federico Perno; Arnaldo Fravolini; Erik De Clercq; Dominique Schols; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

Review 4.  Artificial DNA and surface plasmon resonance.

Authors:  Roberta D'Agata; Giuseppe Spoto
Journal:  Artif DNA PNA XNA       Date:  2012-04-01

5.  Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop.

Authors:  Gregory Upert; Audrey Di Giorgio; Alok Upadhyay; Dinesh Manvar; Nootan Pandey; Virendra N Pandey; Nadia Patino
Journal:  J Nucleic Acids       Date:  2012-09-17

6.  Synthetic genomics and synthetic biology applications between hopes and concerns.

Authors:  Harald König; Daniel Frank; Reinhard Heil; Christopher Coenen
Journal:  Curr Genomics       Date:  2013-03       Impact factor: 2.236

7.  Delivery systems for in vivo use of nucleic Acid drugs.

Authors:  R R Resende; H A M Torres; K K Yuahasi; Majumder P; Ulrich H
Journal:  Drug Target Insights       Date:  2007-08-09

Review 8.  The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention.

Authors:  Miguel Stevens; Erik De Clercq; Jan Balzarini
Journal:  Med Res Rev       Date:  2006-09       Impact factor: 12.944

Review 9.  Aptamers against pathogenic microorganisms.

Authors:  Anna Davydova; Maria Vorobjeva; Dmitrii Pyshnyi; Sidney Altman; Valentin Vlassov; Alya Venyaminova
Journal:  Crit Rev Microbiol       Date:  2015-08-10       Impact factor: 7.624

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.